Performance of the xpert HIV-1 viral load assay: A systematic review and meta-analysis

Journal of Clinical Microbiology

Volumn 56, Issue 4, 2018, Pages

  Nash, Madlen ^a,b   Huddart, Sophie ^a,b   Badar, Sayema ^c   Baliga, Shrikala ^d,e   Saravu, Kavitha ^e,f   Paia, Madhukar ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c TULANE UNIVERSITY   (United States)

^d KASTURBA MEDICAL COLLEGE   (India)

^e MANIPAL UNIVERSITY   (India)

^f KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Accuracy; Diagnosis; HIV; Viral load; Xpert HIV 1

Indexed keywords

ARTICLE; AUTOMATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTERMETHOD COMPARISON; PRIORITY JOURNAL; STANDARD; SYSTEMATIC REVIEW; VIRUS LOAD; XPERT HIV-1 VL ASSAY; DIAGNOSTIC KIT; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; META ANALYSIS; POINT OF CARE TESTING; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

VIRUS RNA;

HIV INFECTIONS; HIV-1; HUMANS; POINT-OF-CARE TESTING; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 85044713163     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01673-17     Document Type: Article

References (24)

1. UNAIDS. 2014. The gap report. UNAIDS, Geneva, Switzerland.
2. Cepheid Technical Support. 2016. Xpert HIV-1 viral load training. Cepheid, Sunnyvale, CA. http://www.cepheid.com/en/cepheid-solutions/clinical-ivd-tests/virology/xpert-hiv-1-viral-load. Accessed 11 December 2017.
3. World Health Organization. 2017. WHO monitoring of Xpert MTB/RIF roll-out. World Health Organization, Geneva, Switzerland. http://www.who.int/tb/areas-of-work/laboratory/mtb-rif-rollout/en/. Accessed 9 February 2017.
4. Cazabon D, Suresh A, Oghor C, Qin ZZ, Kik SV, Denkinger CM, Pai M. 2017. Implementation of Xpert MTB/RIF in 22 high tuberculosis burden countries: are we making progress? Eur Respir J 50:1700918. https://doi.org/10.1183/13993003.00918-2017.
5. World Health Organization. 2016. Global tuberculosis report. World Health Organization, Geneva, Switzerland.
6. Roberts T, Cohn J, Bonner K, Hargreaves S. 2016. Scale-up of routine viral load testing in resource-poor settings: current and future implementation challenges. Clin Infect Dis 62:1043–1048. https://doi.org/10.1093/cid/ciw001.
7. World Health Organization. 2017. WHO prequalification of in vitro diagnostics public report. World Health Organization, Geneva, Switzerland.
8. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100. https://doi.org/10.1371/journal.pmed.1000100.
9. Rucker G, Schwarzer G, Carpenter JR, Schumacher M. 2008. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol 8:79. https://doi.org/10.1186/1471-2288-8-79.
10. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM. 2011. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155: 529–536. https://doi.org/10.7326/0003-4819-155-8-201110180-00009.
11. Ceffa S, Luhanga R, Andreotti M, Brambilla D, Erba F, Jere H, Mancinelli S, Giuliano M, Palombi L, Marazzi MC. 2016. Comparison of the Cepheid GeneXpert and Abbott M2000 HIV-1 real time molecular assays for monitoring HIV-1 viral load and detecting HIV-1 infection. J Virol Methods 229:35–39. https://doi.org/10.1016/j.jviromet.2015.12.007.
12. Gous N, Scott L, Berrie L, Stevens W. 2016. Options to expand HIV viral load testing in South Africa: evaluation of the GeneXpert HIV-1 viral load assay. PLoS One 11:e0168244. https://doi.org/10.1371/journal.pone.0168244.
13. DerSimonian R, Laird N. 1986. Meta-analysis in clinical trials. Control Clin Trials 7:177–188. https://doi.org/10.1016/0197-2456(86)90046-2.
14. Garrett NJ, Drain PK, Werner L, Samsunder N, Abdool Karim SS. 2016. Diagnostic accuracy of the point-of-care xpert HIV-1 viral load assay in a South African HIV clinic. J Acquir Immune Defic Syndr 72:e45–e48. https://doi.org/10.1097/QAI.0000000000000978.
15. Gueudin M, Baron A, Alessandri-Gradt E, Lemee V, Mourez T, Etienne M, Plantier JC. 2016. Performance evaluation of the new HIV-1 quantification assay, Xpert HIV-1 viral load, on a wide panel of HIV-1 variants. J Acquir Immune Defic Syndr 72:521–526.
16. Jordan JA, Plantier JC, Templeton K, Wu AHB. 2016. Multi-site clinical evaluation of the Xpert HIV-1 viral load assay. J Clin Virol 80:27–32. https://doi.org/10.1016/j.jcv.2016.04.014.
17. Mor O, Gozlan Y, Wax M, Mileguir F, Rakovsky A, Noy B, Mendelson E, Levy I. 2015. Evaluation of the realtime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx assays in comparison to the NucliSens EasyQ HIV-1 v20 assay for quantification of HIV-1 viral load. J Clin Microbiol 53: 3458–3465. https://doi.org/10.1128/JCM.01806-15.
18. Moyo S, Mohammed T, Wirth KE, Prague M, Bennett K, Holme MP, Mupfumi L, Sebogodi P, Moraka NO, Boleo C, Maphorisa CN, Seraise B, Gaseitsiwe S, Musonda RM, van Widenfelt E, Powis KM, Gaolathe T, Tchetgen Tchetgen EJ, Makhema JM, Essex M, Lockman S, Novitsky V. 2016. Point-of-care Cepheid Xpert HIV-1 viral load test in rural African communities is feasible and reliable. J Clin Microbiol 54:3050–3055. https://doi.org/10.1128/JCM.01594-16.
19. Bruzzone B, Caligiuri P, Nigro N, Arcuri C, Delucis S, Di Biagio A, Icardi G. 2017. Xpert HIV-1 viral load assay and versant HIV-1 RNA 1.5 assay: a performance comparison. J Acquired Immune Defic Syndr 74:e86–e88. https://doi.org/10.1097/QAI.0000000000001227.
20. Nash M, Ramapuram J, Kaiya R, Huddart S, Pai M, Baliga S. 2017. Use of the GeneXpert tuberculosis system for HIV viral load testing in India. Lancet Glob Health 5:e754–e755. https://doi.org/10.1016/S2214-109X(17)30247-4.
21. Avidor B, Matus N, Girshengorn S, Achsanov S, Gielman S, Zeldis I, Schweitzer I, Adler A, Turner D. 2017. Comparison between Roche and Xpert in HIV-1 RNA quantitation: a high concordance between the two techniques except for a CRF02_AG subtype variant with high viral load titters detected by Roche but undetected by Xpert. J Clin Virol 93:15–19. https://doi.org/10.1016/j.jcv.2017.05.014.
22. Kulkarni S, Jadhav S, Khopkar P, Sane S, Londhe R, Chimanpure V, Dhilpe V, Ghate M, Yelagate R, Panchal N, Rahane G, Kadam D, Gaikwad N, Rewari B, Gangakhedkar R. 2017. GeneXpert HIV-1 quant assay, a new tool for scale up of viral load monitoring in the success of ART pro-gramme in India. BMC Infect Dis 17:506. https://doi.org/10.1186/s12879-017-2604-5.
23. Swathirajan CR, Vignesh R, Boobalan J, Solomon SS, Saravanan S, Balakrishnan P. 2017. Performance of point-of-care Xpert HIV-1 plasma viral load assay at a tertiary HIV care centre in Southern India. J Med Microbiol https://doi.org/10.1099/jmm.0.000514.
24. Hemelaar J, Gouws E, Ghys PD, Osmanov S. 2006. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 20:W13–W23. https://doi.org/10.1097/01.aids.0000247564.73009.bc.